Clinical trial NCT06940167: Comparison of Kinesio Taping and Myofascial Release in Cervicogenic Headache
Official title: Comparison of the Effectiveness of Kinesio Taping and Myofascial Release in Patients With Cervicogenic Headache
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Cervicogenic Headache
Keywords: Cervicogenic headache
Myofascial Release
Kinesio taping
Lead sponsor: Konya Meram State Hospital
Sponsor class: OTHER
First posted: 2025-04-23
Enrollment: 90
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Cervicogenic headache (CGH) is defined as a headache accompanied by neck pain, caused by a disorder in the cervical spine, bones, discs, or soft tissue elements. This study is designed as a prospective, case-control, hospital-based study. A total of 90 patients aged 18-65 years who have been suffering from CGH for at least three months and who present to the Physical Medicine and Rehabilitation Clinic of Meram State Hospital between January 2025 and January 2027 will be included in the study. Patients will be informed about the procedures, and informed consent will be obtained. The study will be conducted in accordance with the Declaration of Helsinki. A detailed medical history will be taken from all participants, and a comprehensive physical examination will be performed. Sociodemographic and clinical characteristics such as age, gender, height, weight, education level, employment status, and income level will be recorded. The 90 CGH patients will be divided into three groups.Group 1 (n=30) will receive myofascial release therapy + home exercise program for four weeks, three sessions per week, totaling 12 sessions. Group 2 (n=30) will receive Kinesio taping + home exercise program for four weeks, three sessions per week, totaling 12 sessions. Group 3 (n=30) will receive only a home exercise program for four weeks, three sessions per week, totaling 12 sessions. All evaluations will be conducted by the same researcher at three time points: before treatment (baseline), at the end of treatment (week 4), and one month after the completion of treatment (week 8).The aim of this prospective clinical study is to compare the effectiveness of Kinesio taping and myofascial release therapy in the treatment of cervicogenic headache.

Detailed description: This randomized, parallel-group clinical trial aims to compare the effectiveness of kinesio taping and myofascial release therapy in patients diagnosed with cervicogenic headache. The study is based on the hypothesis that both interventions can reduce pain intensity and functional disability, but their relative efficacy remains unclear. The trial is designed to provide clinical evidence to guide physiotherapeutic management of cervicogenic headache.

Eligibility criteria: Inclusion Criteria:Individuals aged 18-65 years Neck or headache persisting for at least 3 months

Meeting the diagnostic criteria for cervicogenic headache, including:

* Unilateral pain
* Reduced cervical range of motion
* Ipsilateral shoulder discomfort
* Ipsilateral arm discomfort
* Pain exacerbated by different neck movements and tenderness on palpation

Exclusion Criteria:

Migraine Cluster headache Cervical radiculopathy Entrapment neuropathy Myelopathy Rheumatoid arthritis Undergoing cervical spinal surgery Pregnancy Receiving physical therapy within the last 6 months History of major psychiatric disorders History of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological, etc.) History of uncontrolled endocrine diseases (e.g., Diabetes Mellitus, hyperthyroidism, etc.)

-

Primary outcomes:
measure: Change in Cervicogenic Headache Severity Measured by Visual Analog Scale (VAS) at Baseline, 4 Weeks, and 8 Weeks
timeFrame: Baseline, Week 4 (end of treatment), and Week 8 (1-month follow-up after treatment)
Secondary outcomes:
measure: Change in Headache Impact Test (HIT-6) Score at Baseline, 4 Weeks, and 8 Weeks
timeFrame: Baseline, Week 4, and Week 8
measure: Change in Headache Disability Index (HDI) Score at Baseline, 4 Weeks, and 8 Weeks
timeFrame: Baseline, Week 4, and Week 8
measure: Change in Quality of Life Measured by Short Form-12 (SF-12) at Baseline, 4 Weeks, and 8 Weeks
timeFrame: Baseline, Week 4, and Week 8
measure: Change in Headache Frequency (Number of Headache Days per Month) at Baseline, 4 Weeks, and 8 Weeks
timeFrame: Baseline, Week 4, and Week 8
Other outcomes:
Locations:
city: Konya
country: Turkey
facility: Meram State Hospital
state: Meram
Study officials:
References: